ArticleAmerican heart journal plus : cardiology research and practice2022
Hyperpolypharmacy is a predictor of mortality after left ventricular assist device (LVAD) implantation.
Lauren Dautzenberg et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2022
this paperpooled itcites it